Biomarkers, such as those sought for Alzheimer’s disease, are benchmarks in the body that can be reliably measured to indicate the presence or absence of a disease, or the likelihood … Continue Reading Earliest-ever diagnosing tool for Alzheimer’s becomes international standard.
Worldwide, more than 20% of persons over the age of 85 suffer from Alzheimer’s disease. Deposits of beta-amyloid (Aβ) peptide represent an important target for research into Alzheimer’s disease. These … Continue Reading Researchers take a step towards utilising the brain’s microglia to fight Alzheimer’s disease.
More than five million Americans are living with Alzheimer’s disease (AD). Of them, 400,000 also have Down syndrome. People with Down syndrome (DS) represent the world’s largest population of predetermined … Continue Reading Study validates beta amyloid as cause of dementia in both Alzheimer’s and Down syndrome.
Examining post-mortem tissue from the brains of people with Alzheimer’s disease, Stanford University researchers state they have identified what appear to be iron-containing microglia, specialized scavenger cells that sometimes become … Continue Reading A human study identifies region specific iron-containing microglia in Alzheimer’s brains.
Brain levels of the lipid ceramide are high in Alzheimer’s disease, and now scientists have found increased levels of an antibody to the lipid in their disease model. While some … Continue Reading New study provides more proof that Alzheimer’s is an autoimmune disease.
A new study by researchers at Sanford-Burnham Medical Research Institute reveals the process that leads to changes in the brains of individuals with Down syndrome, the same changes that cause … Continue Reading Why people with Down syndrome invariably develop Alzheimer’s disease.
The peptide, a small protein, beta-amyloid is strongly associated with Alzheimer’s disease; however, researchers are still looking for unequivocal proof that this peptide is the causal agent of the onset … Continue Reading Quantifying the amount and structure of beta-amyloid that is the most harmful to neurons.